Inhalon Biopharma

IN THE PRESS

Drug Development

Inhalon Biopharma Announces Positive Results from Study Demonstrating Superior Safety and Efficacy of its Inhaled Antibody Platform Over Systemic Dosing

March 20, 2024

·

3 min read

Bio NC

Inhalon Biopharma Announces Two Publications Advancing its Inhaled Antibody Treatment Platform for Acute Respiratory Infections

March 14, 2024

·

4 min read

Bio NC

Inhalon Biopharma Secures U.S. Army Medical Research and Development Command Award to Support Development of Inhaled Therapeutics for Treatment of COVID-19

November 15, 2023

·

4 min read

Business

Inhalon Biopharma Expands Therapeutic Horizons with Licensing of hMPV Antibodies from the University of Georgia

November 1, 2023

·

2 min read

Drug Development

Inhalon Doses First Patient in Phase 1 Study of Inhaled IN-006 to Treat COVID-19

October 7, 2021

·

4 min read

JOBS